Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Organon & Co banner

Organon & Co
XMUN:7XP

Watchlist Manager
Organon & Co Logo
Organon & Co
XMUN:7XP
Watchlist
Price: 6.26 EUR 0.38% Market Closed
Market Cap: €1.6B
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Revenue Breakdown

Breakdown by Geography
Organon & Co

Total Revenue: 6.4B USD
100%
Int’l: 4.8B USD
75.4%
Europe And Canada: 1.8B USD
27.5%
United States: 1.6B USD
24.6%
Asia Pacific And Japan: 1.1B USD
16.4%
Latin America, Middle East, Russia, And Africa: 1B USD
16.1%
China: 847m USD
13.2%
Other: 137m USD
2.1%
Show More
Show Less

Breakdown by Segments
Organon & Co

Total Revenue: 6.4B USD
100%
Nexplanon/Implanon Nxt: 963m USD
15%
Atozet: 473m USD
7.4%
Singulair: 359m USD
5.6%
Zetia: 317m USD
5%
Other Non-Opiod Pain, Bone And Dermatology: 295m USD
4.6%
Nasonex: 276m USD
4.3%
Renflexis: 274m USD
4.3%
Arcoxia: 270m USD
4.2%
Cozaar/Hyzaar: 243m USD
3.8%
Follistim Aq: 237m USD
3.7%
Dulera: 203m USD
3.2%
Other Women's Health: 158m USD
2.5%
Fosamax: 151m USD
2.4%
Hadlima: 142m USD
2.2%
Ontruzant: 141m USD
2.2%
Diprospan: 139m USD
2.2%
Marvelon/Mercilon: 134m USD
2.1%
Other Cardiovascular: 133m USD
2.1%
Clarinex: 127m USD
2%
Nuvaring: 115m USD
1.8%
Propecia: 111m USD
1.7%
Ganirelix Acetate Injection: 109m USD
1.7%
Vytorin: 108m USD
1.7%
Emgality/Rayvow: 107m USD
1.7%
Proscar: 95m USD
1.5%
Brenzys: 77m USD
1.2%
Jada: 61m USD
1%
Other Respiratory: 53m USD
0.8%
Rosuzet: 49m USD
0.8%
Aybintio: 28m USD
0.4%
Vtama: 12m USD
0.2%
Show More
Show Less

See Also

Summary
7XP intrinsic value, competitors valuation, and company profile.
DCF Valuation
7XP stock valuation using Discount Cash Flow valuation method.
Relative Valuation
7XP stock valuation using valuation multiples.
Wall Street Estimates
7XP price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
7XP stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 319,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.